Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
Financial Data
-
31st Dec 19 Source: CRO
- €1.7 billion turnover
-
€121.9 million
profit - 183 employees
-
31st Dec 18 Source: CRO
- €13.7 billion turnover
-
€2.4 billion
profit - 22,000 employees
- 11 more years available »
Ranking
By Turnover
(€1.7 billion)- 60th in Top Companies
- 11th in Pharma
By Employees
(183)- 633rd in Top Companies
- 58th in Pharma
-
- 183
- €1.7 billion
Employees
- Susan Hynes Vice President}
Latest News
- 5:07pm Former Mayo footballer acquires project management firm
- 4:16pm BioNTech aims to develop first mRNA-based malaria vaccine
- 3:29pm ‘Total travesty’: 294 submissions made over plan to tackle challenges against planning proposals
- 2:57pm Aon’s $30bn acquisition of Willis Towers Watson collapses
- 2:47pm SSE to explore production of green hydrogen energy in Ireland